Launch in new window

The Local Group - what a time to be alive

You are here

ACT's Brooke van Velden on the Vaccine Mandate and the New Covid-19 Treatment Pill: October 13, 2021.

ACT's Brooke van Velden on the Vaccine Mandate and the New Covid-19 Treatment Pill: October 13, 2021.

ACT's Brooke van Velden on the Vaccine Mandate and the New Covid-19 Treatment Pill: October 13, 2021. , 20.51 MB
Wednesday, October 13, 2021

This week, Zazi speaks to Brooke about the vaccine mandate for teachers and most healthcare workers, as well as the Government signing an advanced purchase agreement for the new Covid-19 treatment pill Molnupiravir.

In the first half, Zazi asks Brooke about whether she believes the vaccine mandate will increase vaccination numbers, whether this mandate will result in workers leaving their place of employment, and whether the tertiary education sector should be included in the madate.

In the second half, Zazi and Brooke talk about ACT's support for the new Covid-19 treatment pill Molnupiravir, the significance of New Zealand being one of the first countries in the world to sign this advanced purchase, as well as the efficiency of Medsafe.